Beneficial Effects from β-Adrenergic Blockade in Elderly Patients Undergoing Noncardiac Surgery
- 1 December 1999
- journal article
- clinical trial
- Published by Wolters Kluwer Health in Anesthesiology
- Vol. 91 (6) , 1674
- https://doi.org/10.1097/00000542-199912000-00020
Abstract
Background: Perioperative beta-blockade has been shown to improve long-term cardiac outcome in noncardiac surgical patients. A possible mechanism for the reduced risk of perioperative myocardial infarction is the attenuation of the excitotoxic effects of catecholamine surges by beta-blockade. It was hypothesized that beta-blocker-induced alteration of the stress response was responsible for the reported improvements in cardiovascular outcome. Several variables associated with the perioperative use of beta-blockade were also evaluated. Methods: Sixty-three patients were randomly assigned to one of three groups: group I, no atenolol; group II, pre- and postoperative atenolol; group III, intraoperative atenolol. Hormonal markers of the stress response (neuropeptide Y, epinephrine, norepinephrine, cortisol, and adrenocorticotropic hormone) were evaluated preoperatively and for 72 h after surgery. Results: Perioperative beta-blockade did not significantly alter the hormonal stress response. However, the beta-blocked patients showed improved hemodynamic stability during emergence and postoperatively. They also received less fentanyl intraoperatively (27.7%, P < 0.0001), experienced faster early recovery, had lower pain scores, and required less analgesia in the postanesthesia care unit. Cardiac troponin I release was detected in 8 of 19, 4 of 20, and 5 of 20 patients in groups I, II, and III, respectively (not significant). Three patients in group I had cardiac troponin I levels consistent with myocardial infarction. Conclusion: Beta-blockade does not reduce the neuroendocrine stress response, suggesting that this mechanism is not responsible for the previously reported improved cardiovascular outcome. However, it confers several advantages, including decreased analgesic requirements, faster recovery from anesthesia, and improved hemodynamic stability. The release of cardiac troponin I suggests the occurrence of perioperative myocardial damage in this elderly population, which appears to be independent of the neuroendocrine stress response.Keywords
This publication has 40 references indexed in Scilit:
- Norepinephrine Stimulates Apoptosis in Adult Rat Ventricular Myocytes by Activation of the β-Adrenergic PathwayCirculation, 1998
- Esmolol Potentiates Reduction of Minimum Alveolar Isoflurane Concentration by AlfentanilAnesthesia & Analgesia, 1998
- Prophylactic Atenolol Reduces Postoperative Myocardial IschemiaAnesthesiology, 1998
- β-adrenergic-Blocking DrugsAnesthesiology, 1998
- A731 ESMOLOL REDUCES NOCICEPTIVE BEHAVIOR IN THE RAT FORMALIN TESTAnesthesiology, 1997
- An Algorithm for Assessing Intraoperative Mean Arterial Pressure LabilityAnesthesiology, 1997
- Reducing Cardiovascular Risk in Patients Undergoing Noncardiac SurgeryNew England Journal of Medicine, 1996
- Effect of Atenolol on Mortality and Cardiovascular Morbidity after Noncardiac SurgeryNew England Journal of Medicine, 1996
- Myocardial Ischemia in Untreated Hypertensive PatientsAnesthesiology, 1988
- β‐Receptor Blockade and Neurolept Anaesthesia. Withdrawal vs Continuation of Long‐Term Therapy in Gall‐Bladder and Carotid Artery SurgeryActa Anaesthesiologica Scandinavica, 1982